Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.

Please provide your email address to receive an email when new articles are posted on . OCT is emerging as a more sensitive test to identify fibrosis. The next step will be to include an en face image ...

A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...

Fibrosis, a characteristic of all chronic kidney diseases (CKD), is now recognized to be an independent predictor of disease ...

For many years, it was believed that when an individual develops liver scarring, it can not be reversed. Today, we know that ...

Cardiovascular disease often culminates in heart failure, a hallmark of which is fibrosis, a form of tissue scarring. Cardiac fibrosis initially repairs damaged heart tissue, but it can quickly become ...

Fibrosis is the body's way of patching up damage—a bit like fixing a pothole. When skin is cut or a muscle is injured, ...

Scientists at the Victor Chang Cardiac Research Institute in Australia have produced a first of its kind integrated map of heart cells which unlocks the process of cardiac fibrosis – a major cause of ...

Researchers have defined a new bodily process in mice that may explain why blood oxygen levels are lower for patients with cystic fibrosis when they get a lung infection. "Infected areas of the lung ...